Your Partner in Advancing
Therapies to Patients
About Us
Your Partner to Global Healthcare
LSC supports the Global Healthcare Industry in introducing therapies to market through crafted insights, commercial strategies, and targeted implementation actions.
In the evolving Lifesciences and Healthcare landscape, enhancing patient care demands visionary transformations. We address challenges and opportunities by redefining care pathways, creating innovative funding schemes, and fostering new collaborations within healthcare ecosystems.
Why LSC
LSC: 20 Years of Global Healthcare Innovation
LSC is a global life sciences-focused commercial strategy consultancy with a 20-year track record of helping Large and Small Cap Biopharma, MedTech, and Diagnostics clients to successfully deliver to market transformative healthcare products and patient-centric solutions in the US, Europe, and Emerging Markets.
Industry Sectors
Main Industry Sectors
LSC can support diverse domains of the Global Healthcare Industry through crafted commercial insights, proprietary methodologies, and actionable commercial strategies.
Biopharma
With extensive global commercialization expertise spanning therapeutic areas and technologies, we specialize in assessing evolving landscapes, aiding decision-making, and implementing product/portfolio strategies throughout the product lifecycle.
MedTech & Diagnostics
LSC helps medical device, diagnostic, and connected healthcare companies to value new opportunities, confirm access to patients in complex healthcare ecosystems, and validate the value of advanced technology-enabled products across the patient journey.
Digital Health & Health IT
LSC aids Digital Health and Health IT firms in comprehending the patient journey within connected ecosystems, evaluating growth opportunities, validating clinical use and business cases for diagnostic tools and management platforms, overcoming adoption barriers, and achieving scalable profitability.
Digital Health & Health IT
LSC aids Digital Health and Health IT firms in comprehending the patient journey within connected ecosystems, evaluating growth opportunities, validating clinical use and business cases for diagnostic tools and management platforms, overcoming adoption barriers, and achieving scalable profitability.
Payers & Insurances
With a wide-spread network of payers and insurers across the globe, LSC can help understand major reimbursement and pricing challenges for products as well as optimizing care strategies of institutional stakeholders, in USA and ex-USA markets.
Digital Health & Health IT
LSC aids Digital Health and Health IT firms in comprehending the patient journey within connected ecosystems, evaluating growth opportunities, validating clinical use and business cases for diagnostic tools and management platforms, overcoming adoption barriers, and achieving scalable profitability.
Emerging Markets Healthcare Systems and Service Providers
We hold almost 20 years of experience in building and delivering commercialization and market entry plans for major emerging markets like LATAM, APAC, AMAC. through innovative commercial models and alternative channels to funding and supply.
Investors
We specialize in delivering pre-deal strategic commercial due diligences as well as designing and implementing growth strategies for portfolio companies for PE and VC investors in biopharmaceuticals, medtech, diagnostics and providers.
Payers & Insurances
With a wide-spread network of payers and insurers across the globe, LSC can help understand major reimbursement and pricing challenges for products as well as optimizing care strategies of institutional stakeholders, in USA and ex-USA markets.
Expertise
Our Therapeutic Areas
Over the past 20 years, LSC has worked on 1000+ projects across all the major areas of the healthcare value chain to provide fresh perspectives and actionable solutions. Our multidisciplinary team of experts, proprietary methodologies, and strong healthcare business understanding help us build coherent strategic solutions that drive successful business outcomes.
Rare Diseases
LSC has assisted multiple large-scale as well as medium-scale pharma companies in understanding the rare disease landscape, reimbursement strategies, pricing options, and adoption drivers, by combining scientific, clinical, regulatory, and patient-centered knowledge, across diverse geographies.
Cell & Gene Therapy
LSC has supported top-5 pharma companies in assessing their ecosystem readiness for cell and gene therapies and building optimal strategies for patient and customer identification, launch, pricing/access, and other pre-commercialization activities, for groundbreaking therapies in a challenging ecosystem.
Neurology / Psychiatry
Neurological disorders, affecting hundreds of millions globally, range from common conditions like Parkinson’s and Alzheimer’s to rarer ones such as multiple sclerosis and neuromuscular diseases. Psychiatric disorders, like anxiety and depression, affect 1 in 8 people worldwide. With nearly two decades of experience, LSC offers expert guidance in understanding healthcare ecosystems, assessing new assets, optimizing strategies, and tailoring launch plans for various disorders across global and local markets.
CVD and Structural Heart
LSC has supported 50+ cardiovascular projects helping companies resolve complex challenges for next generation cardiovascular technologies, product pricing, value proposition optimization, launch preparation and indication expansion.
Inflammatory / Autoimmune
LSC has supported pharma and biotech companies in guiding critical decisions for go-to-market plans, loss of exclusivity situations, value messaging, and product market fit estimation.
Oncology / Hematology
From its inception, LSC has handled 100+ oncology projects spanning across diverse areas like opportunity assessment, clinical plan optimization, commercialization strategy, investment deal benchmarking, pricing, access strategy, and lifecycle management for solid tumors, hem oncology, and rare cancers.
Non-malignant Hematology
LSC hold rich experience in building coherent solution for multiple non-malignant hematologic indications to guide product launch, post-commercialization optimization, market access, and product pricing.
Ophthalmology
With broad experience across multiple ophthalmology indications, LSC has helped global pharma/biotech companies tackle unique challenges in product pricing, clinical adoption, commercialization, portfolio expansion, patient engagement, and acquisition planning.